A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients

NCT01498081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: AZD2115
DRUG: Placebo
DRUG: Indacaterol
DRUG: Indacaterol + Tiotropium

Sponsor

AstraZeneca